HEALTH

Jackson, Miss. named Spring Allergy Capital by AAFA

BY Michael Johnsen

WASHINGTON – The Asthma and Allergy Foundation of American on Thursday released its top 100 list of Spring Allergy Capitals, naming Jackson, Miss. as the leading Allergy Capital in the U.S. based on higher than average pollen and higher than average medication usage. 
 
Nearby, Tennessee posted two cities in the top 10 – Memphis (No. 4) and Knoxville (No. 5). Knoxville, Tenn. climbed to the top-10 list from No. 16 last year. Other cities that reached top 10 status since last year include McAllen, Texas (from No. 10 to No. 6); Wichita, Kansas (No. 12 to No. 7); Dayton, Ohio (No. 11 to No. 8); and Providence, R.I. (No. 17 to No. 9). 
 
AAFA’s Spring Allergy Capitals report is an independent research project of AAFA and is sponsored by Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray distributed by Meda Pharmaceuticals. “The Allergy Capitals can help to inform a pollen sufferer about geographical areas that may provoke and worsen their seasonal symptoms, which impacts
their quality of life,” stated Cliff Bassett, medical director of Allergy and Asthma Care of NY and an ambassador for AAFA. “It’s important that allergy sufferers take heed; a new study by AAFA revealed that spring is when most allergy patients experience their worst seasonal allergy symptoms."
 
The complete list is available at AAFA's website
 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Ad Age: Kimberly Clark is bringing sex appeal to incontinence

BY Michael Johnsen

 

 

 
NEW YORK — The adult incontinence giant Kimberly Clark is shaking up what it means to have bladder leakage with its latest extension of its "Underwearness" campaign that focuses specifically on younger women, according to a report published Wednesday by Ad Age
 
Kimberly-Clark's marketing support fot its Depend products has been skewing younger for some time. Last year, Kimberly Clark launched its "Underwearness" campaign to raise awareness around bladder leakage, suffered by more than 65 million Americans, half of whom are under the age of 50.
 
"It's a recognition that many women with bladder leakage worry that people can tell," Liz Metz, brand director of Depend, told Ad Age. The ads, Metz said, are "recognition that one in three women deal with this issue, and they come in all shapes and sizes."
 
The report noted that the re-entry of Procter & Gamble into the adult incontinence space last year may be upping the ante for consumer attention. 
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Kline: Nasacort Allergy 24HR helped lift allergy sales by 10%

BY Michael Johnsen

PARSIPPANY, N.J. – The significant success of Nasacort Allergy 24 Hour in the past year can be attributed to a combination of product efficacy and retail execution, Laura Mahecha, Kline Healthcare Industry Manger, noted in a recent Kline blog
 
"Despite an already crowded OTC allergy market with stalwarts like oral medications Claritin (Bayer Group), Zyrtec (Johnson & Johnson), and Allegra (Sanofi) and strong penetration by private‑label versions of these major brands, Nasacort Allergy 24 Hour managed to deliver strong sales in its first year on the market," she wrote. "Although Nasacort’s form of being an inhaled medication would have been expected to be a disadvantage for the brand, since most consumers prefer to take oral medications, its increased efficacy compared to traditional antihistamines has proven to be more important," she noted. "Success of the product in year one is also a result of Chattem’s (division of Sanofi) well executed product launch with nationwide multimedia advertising, strong in‑store marketing and displays, and innovative interactive screens on retail shelves helping consumers understand how Nasacort works differently than existing OTC allergy brands.”
 
From February through December 2014, Nasacort generated about $100 million in sales at the manufacturer's level, she noted. Kline pegs the overall allergy market up 10% to over $1.8 billion in sales at the manufacturers’ level.
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?